Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| 1 |
Citigroup
C
|
+$1.11B |
| 2 |
SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$980M |
| 3 |
Booking.com
BKNG
|
+$880M |
| 4 |
Boeing
BA
|
+$843M |
| 5 |
Las Vegas Sands
LVS
|
+$520M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.34B |
| 2 |
Microsoft
MSFT
|
+$1.2B |
| 3 |
Amazon
AMZN
|
+$1.08B |
| 4 |
Meta Platforms (Facebook)
META
|
+$927M |
| 5 |
Netflix
NFLX
|
+$872M |
Sector Composition
| 1 | Technology | 26.64% |
| 2 | Financials | 11.65% |
| 3 | Consumer Discretionary | 9.35% |
| 4 | Healthcare | 9.23% |
| 5 | Industrials | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Chubb
CB
$110B
| $817K | ﹤0.01% |
4,199
+135
| +3% | +$26.3K |
|
727
Ironwood Pharmaceuticals
IRWD
$180M
| $804K | ﹤0.01% |
76,418
+1,171
| +2% | +$12.3K |
|
728
First Trust NASDAQ-100 Equal Weighted Index Fund
QQEW
$1.87B
| $802K | ﹤0.01% |
7,966
-103
| -1% | -$10.4K |
|
729
Philip Morris
PM
$256B
| $800K | ﹤0.01% |
8,226
-2,130
| -21% | -$207K |
|
730
Vitesse Energy
VTS
$987M
| $786K | ﹤0.01% |
+41,285
| New | +$786K |
|
731
Accenture
ACN
$157B
| $751K | ﹤0.01% |
2,627
+58
| +2% | +$16.6K |
|
732
iShares Core MSCI Emerging Markets ETF
IEMG
$104B
| $748K | ﹤0.01% |
15,324
+8,584
| +127% | +$419K |
|
733
Cogent Biosciences
COGT
$1.79B
| $740K | ﹤0.01% |
68,569
| – | – |
|
734
Zimmer Biomet
ZBH
$20.6B
| $739K | ﹤0.01% |
5,711
-841
| -13% | -$109K |
|
735
Celldex Therapeutics
CLDX
$1.61B
| $739K | ﹤0.01% |
20,538
-8,479
| -29% | -$305K |
|
|
PNT
736
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $721K | ﹤0.01% |
99,189
-19,717
| -17% | -$143K |
|
737
Stoneridge
SRI
$230M
| $713K | ﹤0.01% |
+38,124
| New | +$713K |
|
738
iShares US Aerospace & Defense ETF
ITA
$9.21B
| $712K | ﹤0.01% |
6,190
+458
| +8% | +$52.7K |
|
739
iShares TIPS Bond ETF
TIP
$14B
| $684K | ﹤0.01% |
6,199
-1,266
| -17% | -$140K |
|
740
Wells Fargo
WFC
$259B
| $668K | ﹤0.01% |
17,877
-4,072
| -19% | -$152K |
|
|
AFMD
741
DELISTED
Affimed
AFMD
| $667K | ﹤0.01% |
89,522
| – | – |
|
742
Weyerhaeuser
WY
$18.2B
| $667K | ﹤0.01% |
22,127
-120
| -0.5% | -$3.62K |
|
743
WisdomTree
WT
$2.01B
| $654K | ﹤0.01% |
111,632
-1,200
| -1% | -$7.03K |
|
744
Fortinet
FTNT
$61.2B
| $646K | ﹤0.01% |
9,714
-130
| -1% | -$8.64K |
|
745
Mondelez International
MDLZ
$81B
| $645K | ﹤0.01% |
9,254
-799
| -8% | -$55.7K |
|
746
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.03B
| $644K | ﹤0.01% |
26,000
| – | – |
|
747
Comfort Systems
FIX
$25B
| $644K | ﹤0.01% |
4,410
-4,474
| -50% | -$653K |
|
748
Marathon Petroleum
MPC
$55.7B
| $640K | ﹤0.01% |
4,749
-721
| -13% | -$97.2K |
|
749
PNC Financial Services
PNC
$78.9B
| $639K | ﹤0.01% |
5,026
-478
| -9% | -$60.8K |
|
750
Pacific Biosciences
PACB
$393M
| $636K | ﹤0.01% |
54,882
| – | – |
|